Skip to main content Skip to footer
Nighthawk Biosciences, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Biothreat Advisory Board
  • Ecosystem
    • Overview
    • Subsidiaries
  • Products
    • Anthim
    • Publications
  • Investors & News
    • Overview
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Corporate Presentation
  • Careers
  • Contact

Press Releases

Investors & News

Investors & News

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Corporate Presentation
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Dec 02, 2013 8:05am EST

Heat Biologics, Inc. to Present at 25th Annual Piper Jaffray Healthcare Conference

Nov 25, 2013 8:30am EST

Heat Biologics Successfully Completes Manufacturing of HS-410 to Start Phase 1/2 Bladder Cancer Trial

Nov 14, 2013 9:20am EST

Heat Biologics, Inc. Reports Third Quarter 2013 Financial Results and Provides Clinical Programs Review

Oct 02, 2013 10:00am EDT

Heat Biologics, Inc. to Present at 12th Annual BIO Investor Forum

Oct 01, 2013 8:00am EDT

Heat Biologics Files IND for Bladder Cancer Product Candidate

Sep 25, 2013 12:00pm EDT

Heat Biologics Appoints Louis C. Bock to Board of Directors

Sep 19, 2013 10:00am EDT

Heat Biologics, Inc. to Present at Aegis Capital Corp. 2013 Healthcare Conference

Sep 04, 2013 12:55pm EDT

Heat Biologics, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option

Aug 13, 2013 11:43am EDT

Heat Biologics, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option

Jul 29, 2013 12:00pm EDT

Heat Biologics, Inc. Announces Closing of Initial Public Offering of 2,500,000 Shares of Common Stock

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
rss_feed News RSS
NightHawk Biosciences

OUR ECOSYSTEM

SkunkWorx Bio
Elusys Therapeutics Inc.
Scorpius Biological Services
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Nighthawk Biosciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap
  • Visit us on LinkedIn
  • Visit us on Twitter
  • Visit us on YouTube
  • Visit us on Facebook

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.